Novo CEO pressed by Senate to cut prices of obesity, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the business would take into consideration new talks with insurers regarding the checklist selling prices of Wegovy and copyright if they pledge to keep the medicines on their own formularies. https://daveshotchickennutrition86307.blogofoto.com/61850139/the-smart-trick-of-healthcare-news-that-nobody-is-discussing